1. Home
  2. PRTA vs PFIS Comparison

PRTA vs PFIS Comparison

Compare PRTA & PFIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • PFIS
  • Stock Information
  • Founded
  • PRTA 2012
  • PFIS 1905
  • Country
  • PRTA Ireland
  • PFIS United States
  • Employees
  • PRTA N/A
  • PFIS N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • PFIS Major Banks
  • Sector
  • PRTA Health Care
  • PFIS Finance
  • Exchange
  • PRTA Nasdaq
  • PFIS Nasdaq
  • Market Cap
  • PRTA 472.1M
  • PFIS 523.7M
  • IPO Year
  • PRTA N/A
  • PFIS N/A
  • Fundamental
  • Price
  • PRTA $10.45
  • PFIS $46.25
  • Analyst Decision
  • PRTA Buy
  • PFIS
  • Analyst Count
  • PRTA 9
  • PFIS 0
  • Target Price
  • PRTA $17.71
  • PFIS N/A
  • AVG Volume (30 Days)
  • PRTA 567.7K
  • PFIS 19.5K
  • Earning Date
  • PRTA 11-06-2025
  • PFIS 10-30-2025
  • Dividend Yield
  • PRTA N/A
  • PFIS 5.32%
  • EPS Growth
  • PRTA N/A
  • PFIS 582.20
  • EPS
  • PRTA N/A
  • PFIS 5.29
  • Revenue
  • PRTA $11,786,000.00
  • PFIS $182,622,000.00
  • Revenue This Year
  • PRTA N/A
  • PFIS $70.41
  • Revenue Next Year
  • PRTA $672.02
  • PFIS $4.96
  • P/E Ratio
  • PRTA N/A
  • PFIS $8.77
  • Revenue Growth
  • PRTA N/A
  • PFIS 89.84
  • 52 Week Low
  • PRTA $4.32
  • PFIS $38.90
  • 52 Week High
  • PRTA $18.65
  • PFIS $59.70
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 56.63
  • PFIS 45.25
  • Support Level
  • PRTA $10.02
  • PFIS $44.26
  • Resistance Level
  • PRTA $11.17
  • PFIS $46.34
  • Average True Range (ATR)
  • PRTA 0.56
  • PFIS 0.92
  • MACD
  • PRTA -0.07
  • PFIS 0.03
  • Stochastic Oscillator
  • PRTA 37.37
  • PFIS 52.47

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About PFIS Peoples Financial Services Corp.

Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.

Share on Social Networks: